Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Weissmann

Showing results (121-130 of 331) with videos related to

Pageof 34
Sort By:
Lancet (London, England)|October 2, 2002
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trialHossein Ardeschir Ghofrani, Ralph Wiedemann, Frank Rose, et al.
Annals of the New York Academy of Sciences|July 2, 2019
The increase in hemoglobin concentration with altitude varies among human populationsMax Gassmann, Heimo Mairbäurl, Leonid Livshits, et al.
Ebiomedicine|May 14, 2017
Disruption of the Hepcidin/Ferroportin Regulatory System Causes Pulmonary Iron Overload and Restrictive Lung DiseaseJoana Neves, Dominik Leitz, Simone Kraut, et al.
Journal of the American College of Cardiology|October 7, 2004
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective studyHossein A Ghofrani, Robert Voswinckel, Frank Reichenberger, et al.
Pulmonary Circulation|March 13, 2014
Rhodiola: an ordinary plant or a promising future therapy for pulmonary hypertension? a brief reviewDjuro Kosanovic, Xia Tian, Oleg Pak, et al.
Antioxidants & Redox Signaling|April 24, 2015
Unchanged NADPH Oxidase Activity in Nox1-Nox2-Nox4 Triple Knockout Mice: What Do NADPH-Stimulated Chemiluminescence Assays Really Detect?Flávia Rezende, Oliver Löwe, Valeska Helfinger, et al.
Journal of Clinical Medicine|July 8, 2020
Blood Levels of Free-Circulating Mitochondrial DNA in Septic Shock and Postsurgical Systemic Inflammation and Its Influence on Coagulation: A Secondary Analysis of a Prospective Observational StudyEmmanuel Schneck, Fabian Edinger, Matthias Hecker, et al.
Gene Therapy|August 15, 2024
Correction: Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically activeLuca Giordano, Manish K Aneja, Natascha Sommer, et al.
Respiratory Physiology & Neurobiology|May 5, 2004
Basic features of hypoxic pulmonary vasoconstriction in miceNorbert Weissmann, Ercan Akkayagil, Karin Quanz, et al.
Critical Care Medicine|November 21, 2002
Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertensionHossein A Ghofrani, Frank Rose, Ralph T Schermuly, et al.
Pageof 34

Showing results (121-130 of 331) with videos related to

Sort By:
Pageof 34
Lancet (London, England)|October 2, 2002
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trialHossein Ardeschir Ghofrani, Ralph Wiedemann, Frank Rose, et al.
Annals of the New York Academy of Sciences|July 2, 2019
The increase in hemoglobin concentration with altitude varies among human populationsMax Gassmann, Heimo Mairbäurl, Leonid Livshits, et al.
Ebiomedicine|May 14, 2017
Disruption of the Hepcidin/Ferroportin Regulatory System Causes Pulmonary Iron Overload and Restrictive Lung DiseaseJoana Neves, Dominik Leitz, Simone Kraut, et al.
Journal of the American College of Cardiology|October 7, 2004
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective studyHossein A Ghofrani, Robert Voswinckel, Frank Reichenberger, et al.
Pulmonary Circulation|March 13, 2014
Rhodiola: an ordinary plant or a promising future therapy for pulmonary hypertension? a brief reviewDjuro Kosanovic, Xia Tian, Oleg Pak, et al.
Antioxidants & Redox Signaling|April 24, 2015
Unchanged NADPH Oxidase Activity in Nox1-Nox2-Nox4 Triple Knockout Mice: What Do NADPH-Stimulated Chemiluminescence Assays Really Detect?Flávia Rezende, Oliver Löwe, Valeska Helfinger, et al.
Journal of Clinical Medicine|July 8, 2020
Blood Levels of Free-Circulating Mitochondrial DNA in Septic Shock and Postsurgical Systemic Inflammation and Its Influence on Coagulation: A Secondary Analysis of a Prospective Observational StudyEmmanuel Schneck, Fabian Edinger, Matthias Hecker, et al.
Gene Therapy|August 15, 2024
Correction: Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically activeLuca Giordano, Manish K Aneja, Natascha Sommer, et al.
Respiratory Physiology & Neurobiology|May 5, 2004
Basic features of hypoxic pulmonary vasoconstriction in miceNorbert Weissmann, Ercan Akkayagil, Karin Quanz, et al.
Critical Care Medicine|November 21, 2002
Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertensionHossein A Ghofrani, Frank Rose, Ralph T Schermuly, et al.
Pageof 34